|
1
|
Strijkers RH, Cate-Hoek AJ, Bukkems SF and
Wittens CH: Management of deep vein thrombosis and prevention of
post-thrombotic syndrome. BMJ. 343:d59162011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun J, Zhang Z, Ma T, Yang Z, Zhang J, Liu
X, Lu D, Shen Z, Yang J and Meng Q: Endothelial progenitor
cell-derived exosomes, loaded with miR-126, promoted deep vein
thrombosis resolution and recanalization. Stem Cell Res Ther.
9:2232018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Giordano NJ, Jansson PS, Young MN, Hagan
KA and Kabrhel C: Epidemiology, pathophysiology, stratification,
and natural history of pulmonary embolism. Tech Vasc Interv Radiol.
20:135–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Appelen D, van Loo E, Prins MH, Neumann MH
and Kolbach DN: Compression therapy for prevention of
post-thrombotic syndrome. Cochrane Database Syst Rev.
9:CD0041742017.PubMed/NCBI
|
|
5
|
Yan Y, Yang H, Hu X, Zhang Z, Ge S, Xu Z,
Gao J, Liu J, White GC and Ma YQ: Kindlin-3 in platelets and
myeloid cells differentially regulates deep vein thrombosis in
mice. Aging (Albany NY). 11:6951–6959. 2019. View Article : Google Scholar
|
|
6
|
Sato K, Sakamoto K, Hashimoto Y, Hanzawa
K, Sueta D, Kojima S, Fukuda M, Usuku H, Kihara F, Hosokawa H, et
al: Risk factors and prevalence of deep vein thrombosis after the
2016 kumamoto earthquakes. Circ J. 83:1342–1348. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Zhang Z, Wei R, Miao X, Sun S,
Liang G, Chu C, Zhao L, Zhu X, Guo Q, et al: IL (Interleukin)-6
contributes to deep vein thrombosis and is negatively regulated by
miR-338-5p. Arterioscler Thromb Vasc Biol. 40:323–334. 2020.
View Article : Google Scholar :
|
|
8
|
Jia Z, Tu J, Zhao J, Ren B, Tian F, Wang
K, Li S and Jiang G: Aspiration thrombectomy using a large-size
catheter for acute lower extremity deep vein thrombosis. J Vasc
Surg Venous Lymphat Disord. 4:167–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Branchford BR and Carpenter SL: The role
of inflammation in venous thromboembolism. Front Pediatr.
6:1422018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Montfoort ML and Meijers JC: Recent
insights into the role of the contact pathway in
thrombo-inflammatory disorders. Hematology Am Soc Hematol Educ
Program. 2014:60–65. 2014. View Article : Google Scholar
|
|
11
|
Schmaier AH: Physiologic activities of the
contact activation system. Thromb Res. 133(Suppl 1): S41–S44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zamolodchikov D, Renne T and Strickland S:
The Alzheimer's disease peptide beta-amyloid promotes thrombin
generation through activation of coagulation factor XII. J Thromb
Haemost. 14:995–1007. 2016. View Article : Google Scholar :
|
|
13
|
Renne T, Pozgajova M, Gruner S, Schuh K,
Pauer HU, Burfeind P, Gailani D and Nieswandt B: Defective thrombus
formation in mice lacking coagulation factor XII. J Exp Med.
202:271–281. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kleinschnitz C, Stoll G, Bendszus M, Schuh
K, Pauer HU, Burfeind P, Renné C, Gailani D, Nieswandt B and Renné
T: Targeting coagulation factor XII provides protection from
pathological thrombosis in cerebral ischemia without interfering
with hemostasis. J Exp Med. 203:513–518. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matafonov A, Leung PY, Gailani AE, Grach
SL, Puy C, Cheng Q, Sun MF, McCarty OJ, Tucker EI, Kataoka H, et
al: Factor XII inhibition reduces thrombus formation in a primate
thrombosis model. Blood. 123:1739–1746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hess R, Wujak L, Hesse C, Sewald K, Jonigk
D, Warnecke G, Fieguth HG, de Maat S, Maas C, Bonella F, et al:
Coagulation factor XII regulates inflammatory responses in human
lungs. Thromb Haemost. 117:1896–1907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
LaRusch GA, Mahdi F, Shariat-Madar Z,
Adams G, Sitrin RG, Zhang WM, McCrae KR and Schmaier AH: Factor XII
stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to
initiate angiogenesis. Blood. 115:5111–5120. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schonfelder T, Jackel S and Wenzel P:
Mouse models of deep vein thrombosis. Gefasschirurgie. 22:28–33.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tokgoz VY, Sipahi M, Keskin O, Guvendi GF
and Takir S: Protective effects of vitamin D on
ischemia-reperfusion injury of the ovary in a rat model. Iran J
Basic Med Sci. 21:593–599. 2018.PubMed/NCBI
|
|
20
|
Xu L, Yu Y, Sang R, Li J, Ge B and Zhang
X: Protective effects of Taraxasterol against Ethanol-Induced liver
injury by regulating CYP2E1/Nrf2/HO-1 and NF-κB signaling pathways
in mice. Oxid Med Cell Longev. 2018:82841072018. View Article : Google Scholar
|
|
21
|
Lu Y, Wu S, Xiang B, Li L and Lin Y:
Curcumin attenuates oxaliplatin-induced liver injury and oxidative
stress by activating the Nrf2 pathway. Drug Des Devel Ther.
14:73–85. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roumen-Klappe EM, den Heijer M, van Uum
SH, van der Ven-Jongekrijg J, van der Graaf F and Wollersheim H:
Inflammatory response in the acute phase of deep vein thrombosis. J
Vasc Surg. 35:701–706. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tato F: Deep vein thrombosis-advances in
diagnosis and treatment. MMW Fortschr Med. 156(Spec no 2): 59–63;
quiz 64. 2014.In German.
|
|
24
|
Ou M, Zhang Y, Cui S, Zhao S and Tu J:
Upregulated MiR-9-5p protects against inflammatory response in rats
with deep vein thrombosis via inhibition of NF-κB p50.
Inflammation. 42:1925–1938. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Jiang Y, Wan Y, Zhang L, Tang W, Ma
J, Wu S and Cheng W: Medroxyprogestogen enhances apoptosis of
SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway. J
Biomed Res. 27:43–50. 2013.PubMed/NCBI
|
|
26
|
Involvement of pro-inflammatory cytokines
in diabetic neuropathic pain via central PI3K/Akt/mTOR signal
pathway. Arch Physiol Biochem. Dec 11–2019.Epub ahead of print.
View Article : Google Scholar
|
|
27
|
Zhang HB, Tu XK, Chen Q and Shi SS:
Propofol reduces inflammatory brain injury after subarachnoid
hemorrhage: Involvement of PI3K/Akt pathway. J Stroke Cerebrovasc
Dis. 28:1043752019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chang MC, Chen YJ, Liou EJ, Tseng WY, Chan
CP, Lin HJ, Liao WC, Chang YC, Jeng PY and Jeng JH:
7-Ketocholesterol induces ATM/ATR, Chk1/Chk2, PI3K/Akt signalings,
cytotoxicity and IL-8 production in endothelial cells. Oncotarget.
7:74473–74483. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su XL, Su W, Wang Y, Wang YH, Ming X and
Kong Y: The pyrrolidinoindoline alkaloid Psm2 inhibits platelet
aggregation and thrombus formation by affecting PI3K/Akt signaling.
Acta Pharmacol Sin. 37:1208–1217. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu F, Huang X, He JJ, Song C, Peng L,
Chen T and Wu BL: Plantamajoside attenuates inflammatory response
in LPS-stimulated human gingival fibroblasts by inhibiting PI3K/AKT
signaling pathway. Microb Pathog. 127:208–211. 2019. View Article : Google Scholar
|
|
31
|
Zhou W, Yuan G and Wang Q: Vitamin D
attenuates lipopoly-saccharide-induced inflammatory response in
endothelial cells through inhibition of PI3K/Akt/NF-κB signaling
pathway. Pharmazie. 74:412–417. 2019.PubMed/NCBI
|
|
32
|
Maas C and Renne T: Coagulation factor XII
in thrombosis and inflammation. Blood. 131:1903–1909. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hopp S, Albert-Weissenberger C, Mencl S,
Bieber M, Schuhmann MK, Stetter C, Nieswandt B, Schmidt PM,
Monoranu CM, Alafuzoff I, et al: Targeting coagulation factor XII
as a novel therapeutic option in brain trauma. Ann Neurol.
79:970–982. 2016. View Article : Google Scholar : PubMed/NCBI
|
